Stay updated with breaking news from Herbert Virgin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) saw strong trading volume on Thursday . 21,924 shares were traded during trading, a decline of 98% from the previous session’s volume of 1,398,276 shares.The stock last traded at $26.13 and had previously closed at $25.91. A number of analysts have issued reports on the stock. Needham & […]
Nordea Investment Management AB increased its position in Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) by 1,501.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 149,025 shares of the company’s stock after acquiring an additional 139,722 shares during the period. Nordea Investment Management AB’s holdings in Vir Biotechnology were worth $6,214,000 at the […]
Zacks Investment Research cut shares of Vir Biotechnology (NASDAQ:VIR – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious […]
The immunology specialist says it can help combat omicron.